---
title: "Eyebright Medical: Number of shares issued 3.5936 million"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/240002177.md"
description: "Eyebright Medical announced that the company will issue 3.5936 million shares of stock to specific targets through a simplified procedure for the year 2024, with an issue price of 79.2 yuan per share, raising a total of 285 million yuan, with a net amount of 281 million yuan. The share registration procedures were completed on May 12, 2025, and the expected listing date is the next trading day after the lock-up period expires. This issuance will not change the company's control, and the controlling shareholder remains Xie Jiangbing"
datetime: "2025-05-13T11:09:52.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/240002177.md)
  - [en](https://longbridge.com/en/news/240002177.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/240002177.md)
generator: "portal-rs"
---

# Eyebright Medical: Number of shares issued 3.5936 million

Eyebright Medical announced that the number of shares to be issued in 2024 through a simplified procedure to specific targets is 3.5936 million shares, with an issue price of 79.2 yuan per share. The total amount of funds raised is 285 million yuan, and the net amount of funds raised is 281 million yuan. The newly issued shares have completed the registration procedures at the Shanghai branch of China Securities Depository and Clearing Corporation Limited on May 12, 2025, and the expected listing date is the next trading day after the expiration of the lock-up period. This issuance will not result in a change of control of the company, and the controlling shareholder and actual controller remain Xie Jiangbing

### Related Stocks

- [688050.CN](https://longbridge.com/en/quote/688050.CN.md)

## Related News & Research

- [Viromed Medical’s Heike Perbandt, closely associated with managing body member Uwe Perbandt, sells shares for EUR 52,000](https://longbridge.com/en/news/298227013.md)
- [SynAct Pharma bolsters resomelagon data as it readies Phase 3 and weighs strategic deals](https://longbridge.com/en/news/298195637.md)
- [WindGroove Introduces AirFi One, a Ceiling-Based Home Entertainment System Combining Hi-Fi Sound, Light, and Airflow](https://longbridge.com/en/news/298221464.md)
- [Trump's latest threat - to stop trading with some countries unless there's a rate cut - risks shock to U.S. economy](https://longbridge.com/en/news/298067979.md)
- [Cyclezyme to buy Ragn-Sells melanin patent, pays via shares for 7.9% stake](https://longbridge.com/en/news/298137821.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**